Clinical trial · Interventional
Artificial Intelligence-based Voice Assessment of Children and Adults Respiratory Conditions
Artificial Intelligence-based Voice Assessment of Children and Adults With Acute and Chronic Respiratory Conditions: Diagnostic and Prognostic Role
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Acute and Chronic respiratory conditions represent a leading cause of death and morbidity in children and adults worldwide. The diagnosis of bronchiolitis and asthmatic exacerbations is based on clinical, and mostly subjective, clinical parameters with moderately accurate prognostic role. Patients undergoing neck radiotherapy need invasive assessments of larynx. A simple biomarker like Voice may facilitate the management of these conditions. Recent studies showed that VOICE may be used as a good and easy biomarker to diagnose and monitor several respiratory and non-respiratory conditions. A prospective study aimed to collected VOICE and other clinical data in adults and children with common acute and chronic respiratory conditions at high impact on healthcare systems will be performed. VOICE-omic data will be linked with clinical findings generating data integration, using artificial intelligence technology to develop a Decision Support Systems to provide the basis for non-invasive personalised early recognition, diagnosis, monitoring and prognosis of patients with these conditions.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Airway Disease | — | UNRESOLVED | — |
| Asthma | — | UNRESOLVED | — |
| Bronchiolitis | — | UNRESOLVED | — |
| Cancer of Head and Neck | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Radiotherapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Wevosys acoustic analysis | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Case group
- description
- children with bronchiolits, controlled asthma and asthmatic re-exacerbations and adults with primary upper aero-digestive tract affections or secondary to radiotherapy
- interventionNames
- Device: Wevosys acoustic analysis
Primary outcomes (16)
- measure
- Acoustic parameters of voice signal in children
- timeFrame
- enrollment; 24 and 48 hours post-therapy; 24 months
- description
- Fundamental frequency (F0), measured in Hertz, is defined as the number of times a sound wave produced by the vocal cords repeats during a given time period, it is also the number of cycles of opening/closure of the glottis.
- measure
- Acoustic parameters of voice signal in children
- timeFrame
- enrollment; 24 and 48 hours post-therapy; 24 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Months
- Maximum age
- 70 Years
Show eligibility criteria text
INCLUSION CRITERIA: * Children with bronchiolitis \<24 months of age clinically characterized according to the clinical definition accepted by international literature (Ralstone); * Children with asthma according to most recent GINA guidance (Global Initiative for Asthma, 2022) aged 6-12 years in a phase of proper control or during acute exacerbations; * Adults with upper aerodigestive tract chronic or acute clinical conditions; * Adults with pathologic diagnosis of head and neck cancer addressed to radiotherapy with or without chemotherapy for primary treatment of the tumor. EXCLUSION CRITERIA: * Children with comorbidities including genetic disorders; * Children with other chronic respiratory conditions (bronchodysplasia, cystic fibrosis); * Children with primary immunologic diseases; * Children with prematurity; * Children with other respiratory conditions not part of the inclusion criteria (examples: pneumonia, tonsillitis); * Adults over 70 years old or with neurological diseases; * Adults with syndromic disease; * Adults with malformations of upper aero-digestive tract; * Adults with history of head and neck surgery or not able to sustain a vocalism for more than 3 sec.
References
Publications (0)
Data not yet available